Phenotype: Ventricular tachycardia, catecholaminergic polymorphic, 1


OMIM: 604772
Inheritance: Autosomal dominant
Classification: Diseases of the circulatory system

Related informations: Orphanet    Gene Tests    Clinical Synopsis    Clinical Trials

RYR2 || c.1069G>A

Gene/Locus:    RYR2
Dna Change:    c.1069G>A
Protein Change:    p.Gly357Ser
Mutation Type:    Substitution
Mutation Effect:    Missense
Location:    exon 13
Transcript:    NM_001035.2

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
SpainNANAlarge familyNAWangüemert F et al., 2015Wangüemert F, Bosch Calero C, Pérez C, Campuzano O, Beltran-Alvarez P, Scornik FS, Iglesias A, Berne P, Allegue C, Ruiz Hernandez PM, Brugada J, Pérez GJ, Brugada R, . Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.. Heart Rhythm. 2015; 12(7):1636-43

References

Wangüemert F, Bosch Calero C, Pérez C, Campuzano O, Beltran-Alvarez P, Scornik FS, Iglesias A, Berne P, Allegue C, Ruiz Hernandez PM, Brugada J, Pérez GJ, Brugada R, Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.Heart Rhythm. 2015; 12(7):1636-43